NEW YORK – Gritstone Oncology, an Emeryville, California-based company developing personalized immunotherapies, on Monday said it has raised $125 million from two private placements of its publicly traded shares.
To read the full story....
...and receive Weekly News bulletins.
Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.
Don't have a Precision Oncology News or 360Dx or GenomeWeb account?
Register for Free.